Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

SERUM, B1A GLOBULIN C3C GOAT ANTI-HUMAN

K-Number: K760148 · 1976-07-20

ApplicantOxford Laboratories, Inc.
Decision Date1976-07-20
Product CodeCZW
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

SERUM, B1A GLOBULIN C3C GOAT ANTI-HUMAN is the device name listed in this FDA 510(k) record. The listed applicant is Oxford Laboratories, Inc.. It received FDA 510(k) clearance on 1976-07-20 under 510(k) number K760148. The device is classified under product code CZW. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the SERUM, B1A GLOBULIN C3C GOAT ANTI-HUMAN?

SERUM, B1A GLOBULIN C3C GOAT ANTI-HUMAN is a medical device that received FDA 510(k) clearance on 1976-07-20. The listed applicant is Oxford Laboratories, Inc.. The 510(k) number is K760148.

When did SERUM, B1A GLOBULIN C3C GOAT ANTI-HUMAN receive FDA 510(k) clearance?

SERUM, B1A GLOBULIN C3C GOAT ANTI-HUMAN received FDA 510(k) clearance on 1976-07-20, under 510(k) number K760148.

Who is the listed applicant for SERUM, B1A GLOBULIN C3C GOAT ANTI-HUMAN?

The FDA 510(k) record lists Oxford Laboratories, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for SERUM, B1A GLOBULIN C3C GOAT ANTI-HUMAN?

The FDA product code for SERUM, B1A GLOBULIN C3C GOAT ANTI-HUMAN is CZW.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Oxford Laboratories, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K780912ADJUSTABLE DISPENSORK760144SERUM, HAPTOGLOBIN GOAT ANTI-HUMAN ACIDK760078REAGENT, RIA TRIIODOTHYRONINE T3 (#200)K760143SERUM, ALPHA-1-GLYCOPROTEIN ANTI-HUMANK760079REAGENT, THYROXINE T4 (#210)K760147SERUM, IGM ANTI-HUMAN ACID

View all 9 devices →

Related Devices (Code: CZW)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K100179SPAPLUSThe Binding Site Group , Ltd.K063150COMPLEMENT C3 AND C4, SPECICAL CALIBRATOR AND SPECITROL CONTROL AND HIGH CONTROLThermo Electron OYK061852DIMENSION VISTA C3 AND C4 FLEX REAGENT CARTRIDGE, PROTEIN 1 CALIBRATOR, CONTROL LOW, MEDIUM, HIGHDade Behring, Inc.K050665N ANTISERA TO HUMAN COMPLEMENT FACTORS (C3C, C4)Dade Behring, Inc.K042494VITROS CHEMISTRY PRODUCTS C3 AND CR REAGENT, CALIBRATOR KIT 20, PROTEIN PERFORMANCE VERIFIERS I, II, AND IIIOrtho-Clinical DiagnosticsK032796IBL C3D-CIC EIA TESTIbl GmbH

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑